Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture, research and development of active pharmaceutical ingredients (API). Its products include pain management for skeletal muscle pain & migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole, caspofungin & micafungin, oncology that act against cancers, lowering cholesterol & chronic heart disease and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company